Migranal
NDC Package 0187-0245-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Migranal is a medication used to treat migraine headache attacks. Marketed by Bausch Health Us, Llc, this product is identified by NDC 0187-0245 and is authorized under FDA application NDA020148.

Identification & Billing

NDC Package Code
0187-0245-01
Package Description
1 VIAL in 1 KIT / 1 mL in 1 VIAL
Product Code
11-Digit Billing Format
00187024501

Clinical Specifications

Proprietary Name
Migranal
Dosage Form
-
Usage Information
This medication is used to treat migraine headache attacks. It helps relieve headache pain and other symptoms such as sensitivity to light or sound. Prompt treatment allows you to get back to your normal routine sooner and may decrease your need for other pain medications. This medication is not used to prevent migraines from occurring. Dihydroergotamine belongs to a class of drugs known as ergot alkaloids. It may work by narrowing the blood vessels in the brain. It may also block other pain pathways in the brain.

Regulatory & Marketing

Labeler Name
Bausch Health Us, Llc
FDA Application #
NDA020148
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-08-1997
End Marketing Date
12-31-2024
Listing Expiration
12-31-2024
Exclude Flag
D
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0187-0245). Click a package code to view its specific billing and regulatory data.

8 VIAL in 1 KIT / 1 mL in 1 VIAL
1 VIAL in 1 KIT / 1 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0187-0245-01 identifies a specific commercial package of 1 vial in 1 kit / 1 ml in 1 vial of Migranal, labeled by Bausch Health Us, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bausch Health Us, Llc on December 08, 1997. The current certification is valid through December 31, 2024.

What are the primary indications for this medication?

This medication is used to treat migraine headache attacks. It helps relieve headache pain and other symptoms such as sensitivity to light or sound. Prompt treatment allows you to get back to your normal routine sooner and may decrease your need for other pain medications. This medication is not used to prevent migraines from occurring. Dihydroergotamine belongs to a class of drugs known as ergot alkaloids. It may work by narrowing the blood vessels in the brain. It may also block other pain pathways in the brain.

How is this Bausch Health Us, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187024501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0187-0245-01
11-Digit CMS (5-4-2)
00187-0245-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.